Guillain-Barré syndrome
Guillain-Barre syndrome (SGB, acute polyradiculoneuritis) is an acute autoimmune inflammatory polyradiculoneuropathy manifested by lethargic paresis, sensitivity disorders, vegetative disorders. The description of the syndrome was published in 1916 by French doctors Georges Guillain and Jean Barré and named after them.
Content |
2022: Johnson & Johnson's coronavirus vaccine is 20 times more likely to cause syndrome than others
On April 26, 2022, a study was published according to which the Johnson & Johnson vaccine for COVID-19 is 20 times more likely to cause Guillain-Barré syndrome in vaccinated compared to other drugs for the prevention of coronavirus infection. More details here.
2021
Risk of Guillain-Barré syndrome after vaccine use AstraZeneca
In September 2021, EMA released an important update: new side effects of the vaccine from COVID-19 by AstraZeneca are reported.
The European drug regulator added a rare nervous disorder, Guillain-Barré syndrome (GBS), as a possible side effect of the vaccine.
The regulator also noted some other less serious vaccine side effects from Johnson & Johnson, Moderna and AstraZeneca.
Muscovite revealed Guillain-Barre syndrome after Sputnik V vaccination
JSC "Medicine" (clinic of Academician Roitberg) together with FGAOU VO "RNIIMU named after N.I. Pirogov " Ministry of Health of the Russian Federation presented the results of a clinical observation of a 47-year-old patient from Moscow the development of clinically confirmed Guillain-Barré syndrome, which occurred 18 days after administration. vaccines Satellite V This was announced by Medicine JSC Zdrav.Expert on May 4, 2021.
The man received his first vaccine with the drug Sputnik V at the end of December 2020, after 18 days he needed medical care.
The patient entered the hospital of the blade on January 18, 2021, he experienced weakness in his legs, had constipation requiring the use of Donbass, and experienced problems with urination. Four days before the alarming symptoms, the patient spoke about hypothermia, which entailed facial asymmetry on the left side and teardrop. After a number of studies, diagnosis and treatment, the patient was discharged from the clinic in a satisfactory condition. As of May 2021, he is under the supervision of a neurologist. According to experts, a feature of this clinical observation was the development of neurological symptoms after the introduction of the Sputnik V vaccine, which the patient made for the prevention of COVID-19, 18 days before the first suspicious symptoms.
 | This clinical observation was one of the first observations of a patient with the development of serious neurological complications after COVID-19 vaccination. Guillain-Barré syndrome is a severe autoimmune disease of the peripheral nervous system, in which the human immune system affects its own peripheral nerves and, as a rule, leads to the development of acute lethargic tetraparesis. Fortunately, such reactions, we doctors, in our practice, are quite rare. And this case will undoubtedly go down in history the Russian sciences medicine in the field of the study of coronavirus infection in order to obtain a comprehensive information account of possible early and distant complications in vaccination against COVID-19. noted 'the head of the scientific group of researchers, academician of the Russian Academy of Sciences, Doctor, Professor, Head of the Department of Therapy, General Medical Practice and Nuclear Medicine, RNIMU named after N.I. Pirogov, President of Medicine JSC Grigory Roitberg. '
|  |
See also
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |